Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
09/2005
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949538 Compounds, compositions, and methods
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005CA2299355C Aryloxyarylsulfonylamino hydroxamic acid derivatives
09/27/2005CA2245680C Method of detection of influenza virus and compounds for use therein
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005US20050209292 Cancer therapy
09/22/2005US20050209278 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050209166 Metabolic disorders like diabetes; inhibits sodium-dependent glucose cotransporter; 1-chloro-2-(4-cyclopentyloxybenzyl)-4-( beta -D-glucopyranos-1-yl)-benzene
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005CN1671682A Azulene derivatives and salts thereof
09/21/2005CN1219802C Copolymer resin, preparation thereof, and photo resist using the same
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946467 Serine protease inhibitors
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085170A1 Ester derivatives of rhein and their therapeutic use
09/15/2005WO2005084349A2 Compounds useful for the synthesis of (+)-discodermolide and methods therefor
09/15/2005US20050203315 Oxidizing 1-(hydroxy-phenylmethyl) cyclohexanol with oxygen in the presence a copper complex salt and a base
09/15/2005DE102004010219A1 HKI10311129, neues Antibiotikum, Verfahren zu dessen Herstellung und dessen Verwendung HKI10311129, new antibiotic, to processes for its preparation and its use
09/15/2005DE102004009569A1 Verwendung von Kern-Mantel-Partikeln Using core-shell particles
09/15/2005CA2558082A1 Ester derivatives of rhein and their therapeutic use
09/14/2005EP1572620A2 Method for the production of optically active dihydropyrones
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005CN1668729A Fragrance composition
09/09/2005WO2005082878A1 Hki10311129, novel antibiotic, method for producing the same and the use thereof
09/08/2005US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin
09/08/2005US20050197498 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
09/08/2005US20050197369 Compounds useful for the synthesis of (+)-discodermolide and methods therefor
09/06/2005US6939845 Fragrance precursors
09/01/2005WO2005080475A2 Use of core-shell particles for producing inverse-opal structures
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080318A1 PROCESSES FOR PRODUCTION OF α-AMINOOXYKETONES AND α-HYDROXYKETONES
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses
09/01/2005US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1568774A2 Recombinant production of novel polyketides
08/31/2005EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1363516B1 An improved process for preparing simvastatin
08/31/2005CN1662853A Onium salts and the use therof as latent acids
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/25/2005WO2005077928A1 Improved process for producing simvastatin
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050187111 (2-halo-4-ethylphenyl)acetic acids and esters and 2-(2-halo-4-ethylphenyl)-1,1,1-trichloroethanes, useful as intermediates for the preparation of phenyl-substituted cyclic ketoenol pesticides and herbicides
08/25/2005US20050187110 Novel herbicides
08/24/2005EP1565450A1 Tetrahydropyran derivatives
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/18/2005WO2005075491A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
08/18/2005US20050182263 Desilylation of 4-silyloxytetrahydropyran-2-ones, by triethylamine trihydrofluoride in an organic solvent; no additional impurities
08/18/2005US20050182131 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
08/18/2005US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors
08/18/2005US20050182040 Benzamide derivatives
08/18/2005US20050181496 Process for preparing purified s-bel and r-bel and compositions thereof
08/18/2005CA2519329A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1655677A Use of ester compound for controlling harmful arthropod
08/17/2005CN1215064C A process for producing simvastatin
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6929896 Iodonium or sulfonium compounds as photosensitive acid donors in the preparation of colour filters or chemically amplified resists
08/11/2005WO2005073211A1 Pyranone derivatives useful for treating cancer
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005US20050176810 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
08/11/2005US20050176783 Substituted aromatic-ring compounds, process for producing the same and use
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176653 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
08/11/2005CA2553318A1 Pyranone derivatives useful for treating cancer
08/10/2005EP1487814B1 Process for the preparation of 4-oxytetrahydropyran-2-ones
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/09/2005US6927300 Process for the preparation of Latanoprost
08/09/2005US6927217 HIV protease inhibitors
08/09/2005US6927057 Macrolide analogs
08/04/2005WO2005070911A1 Transacetalisation process
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005069741A2 Process for producing simvastatin using novel hydrazide intermediates
08/04/2005WO2005035489A3 Improved synthesis of discodermolide and variants thereof
08/04/2005WO2005030188A3 Phenyl-piperazine derivatives as modulators of muscarinic receptors
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 129